CRNX: Crinetics Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3,002.15
Enterprise Value ($M) 2,907.58
Book Value ($M) 1,254.00
Book Value / Share 13.41
Price / Book 2.39
NCAV ($M) 1,183.73
NCAV / Share 12.66
Price / NCAV 2.54

Profitability (mra)
Return on Invested Capital (ROIC) -0.25
Return on Assets (ROA) -0.34
Return on Equity (ROE) -0.38

Liquidity (mrq)
Quick Ratio 22.53
Current Ratio 22.53

Balance Sheet (mrq) ($M)
Current Assets 1,291.06
Assets 1,361.33
Liabilities 107.33
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1.04
Operating Income -338.85
Net Income -298.41
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -225.97
Cash from Investing -574.82
Cash from Financing 1,010.43

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
05-12 13G/A Fmr Llc 15.00 44.91
04-07 13G/A Vanguard Group Inc 10.00 2.44
02-10 13G/A Wellington Management Group Llp 7.50 55.85
11-14 13G/A EcoR1 Capital, LLC 4.80 3.19
11-14 13G Price T Rowe Associates Inc /md/ 6.20
11-14 13G/A Point72 Asset Management, L.P. 2.90 -32.67
10-17 13G/A State Street Corp 3.60 -20.35

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Form 10-K (Mark One)
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-06-03 140,943 534,709 26.36
2025-06-02 176,412 646,199 27.30
2025-05-30 106,723 490,639 21.75
2025-05-29 151,378 1,207,368 12.54

(click for more detail)

Similar Companies
CPIX – Cumberland Pharmaceuticals Inc. CRBU – Caribou Biosciences, Inc.
CRGX – CARGO Therapeutics, Inc. CTMX – CytomX Therapeutics, Inc.
CYTK – Cytokinetics, Incorporated


Financial data and stock pages provided by
Fintel.io